Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
IPS101A in Parkinson Disease: NCT07371338 Clinical Landscape Report 2026
9 min read
IPS101A in Parkinson Disease: NCT07371338 Clinical Landscape Report 2026
16 October 2026
NCT07371338 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tegafur/Gimeracil/Oteracil Potassium in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07374250 Clinical Landscape Report 2026
9 min read
Tegafur/Gimeracil/Oteracil Potassium in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07374250 Clinical Landscape Report 2026
16 October 2026
NCT07374250 clinical landscape for Locally Advanced Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context a…
Read →
OMTX-705 in Pancreatic adenocarcinoma metastatic: NCT07377045 Clinical Landscape Report 2026
9 min read
OMTX-705 in Pancreatic adenocarcinoma metastatic: NCT07377045 Clinical Landscape Report 2026
16 October 2026
NCT07377045 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
TGI-5 in Hepatocellular Carcinoma: NCT07376707 Clinical Landscape Report 2026
9 min read
TGI-5 in Hepatocellular Carcinoma: NCT07376707 Clinical Landscape Report 2026
16 October 2026
NCT07376707 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Melatonin in stress oxidative: NCT07375693 Clinical Landscape Report 2026
9 min read
Melatonin in stress oxidative: NCT07375693 Clinical Landscape Report 2026
16 October 2026
NCT07375693 clinical landscape for stress oxidative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
TROP2-CAR-NK(M.D. Anderson Cancer Center) in Pancreatic Ductal Adenocarcinoma: NCT07377526 Clinical Landscape Report 2026
9 min read
TROP2-CAR-NK(M.D. Anderson Cancer Center) in Pancreatic Ductal Adenocarcinoma: NCT07377526 Clinical Landscape Report 2026
16 October 2026
NCT07377526 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
161Tb-LNC1011 in Metastatic castration-resistant prostate cancer: NCT07381582 Clinical Landscape Report 2026
9 min read
161Tb-LNC1011 in Metastatic castration-resistant prostate cancer: NCT07381582 Clinical Landscape Report 2026
16 October 2026
NCT07381582 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
Anrikefon in Kidney Failure, Chronic: NCT07380113 Clinical Landscape Report 2026
9 min read
Anrikefon in Kidney Failure, Chronic: NCT07380113 Clinical Landscape Report 2026
16 October 2026
NCT07380113 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Olaparib in Solid tumor: NCT07382544 Clinical Landscape Report 2026
9 min read
Olaparib in Solid tumor: NCT07382544 Clinical Landscape Report 2026
16 October 2026
NCT07382544 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Nimotuzumab in Pancreatic carcinoma non-resectable: NCT07386704 Clinical Landscape Report 2026
9 min read
Nimotuzumab in Pancreatic carcinoma non-resectable: NCT07386704 Clinical Landscape Report 2026
16 October 2026
NCT07386704 clinical landscape for Pancreatic carcinoma non-resectable: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →
Lemborexant in Sleep Initiation and Maintenance Disorders: NCT07384429 Clinical Landscape Report 2026
9 min read
Lemborexant in Sleep Initiation and Maintenance Disorders: NCT07384429 Clinical Landscape Report 2026
16 October 2026
NCT07384429 clinical landscape for Sleep Initiation and Maintenance Disorders: endpoints, sponsor, phase, geography, readouts, asset context and development…
Read →
Albumin-Bound Paclitaxel in CLDN18.2 positive Pancreatic Cancer: NCT07383922 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in CLDN18.2 positive Pancreatic Cancer: NCT07383922 Clinical Landscape Report 2026
16 October 2026
NCT07383922 clinical landscape for CLDN18.2 positive Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →